Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: A trial-based analysis

Rheumatology (United Kingdom)

Volumn 52, Issue 8, 2013, Pages 1485-1491

  Jowett, Sue ^a   Crawshaw, Dickon P ^b,c   Helliwell, Philip S ^c   Hensor, Elizabeth M A ^c,d   Hay, Elaine M ^e   Conaghan, Philip G ^c,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LEEDS COMMUNITY HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Chapel Allerton Hospital   (United Kingdom)

^e KEELE UNIVERSITY   (United Kingdom)

Author keywords

Corticosteroid injections; Cost; Cost effectiveness; Economic evaluation; Shoulder exercise; Shoulder pain

Indexed keywords

CORTICOSTEROID;

ADULT; ARM EXERCISE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SHOULDER IMPINGEMENT SYNDROME; SHOULDER PAIN; SHOULDER PAIN AND DISABILITY INDEX;

CORTICOSTEROID INJECTIONS; COST; COST-EFFECTIVENESS; ECONOMIC EVALUATION; SHOULDER EXERCISE; SHOULDER PAIN;

ADRENAL CORTEX HORMONES; ADULT; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHOULDER IMPINGEMENT SYNDROME; SHOULDER PAIN; TREATMENT OUTCOME;

EID: 84880575163     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket149     Document Type: Article

References (25)

1. van der Windt DA, Koes BW, de Jong BA et al. Shoulder disorders in general practice: incidence, patient characteristics, and management. Ann Rheum Dis 1995;54:959-64.
2. van der Windt DA, Koes BW, Boeke AJ, et al. Shoulder disorders in general practice: prognostic indicators of outcome. Br J Gen Pract 1996;46:519-23.
3. Linsell L, Dawson J, Zondervan K, et al. Prevalence and incidence of adults consulting for shoulder conditions in UK primary care; patterns of diagnosis and referral. Rheumatology 2006;45:215-21.
4. Urwin M, Symmons D, Allison T, et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis 1998;57:649-55.
5. Chard MD, Hazleman R, Hazleman BL, et al. Shoulder disorders in the elderly: a community survey. Arthritis Rheum 1991;34:766-9.
6. Walker-Bone K, Palmer KT, Reading I, et al. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum 2004;51: 642-51.
7. Jones JR, Hodgson JT, Clegg TA, et al. Self-reported work-related illness in 1995. Norwich: HMSO, 1998.
8. James M, Stokes EA, Thomas E, et al. A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. Rheumatology 2005;44:1447-51.
9. McKenna C, Bojke L, Manca A, et al. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis. Rheumatology 2009;48:558-63.
10. Crawshaw DP, Helliwell PS, Hensor EM, et al. Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial. BMJ 2010;340:c3037.
11. Roach KE, Budiman-Mak E, Songsiridej N, et al. Development of a shoulder pain and disability index. Arthritis Care Res 1991;4:143-9.
12. Hay EM, Thomas E, Paterson SM, et al. A pragmatic randomised controlled trial of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. Ann Rheum Dis 2003;62:394-9.
13. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
14. Dolan P. Modelling valuations for health states. Med Care 1997;11:1095-108.
15. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15.
16. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487-96.
17. Annual survey of hours and earnings (ASHE). Office for National Statistics, 2011 Provisional results. http://www.ons.gov.uk/ons/rel/ashe/annual-survey-of-hours-andearnings/2011-provisional-results-soc-2010-/index.html (22 October 2012, date last accessed).
18. Office for National Statistics. Standard Occupational Classification 2010 (SOC2010). The structure and index. Vol. 2. http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-classifications/soc2010/soc2010-volume-2-the-structure-and-index/index.html (22 October 2012, date last accessed).
19. Sculpher M. The role of productivity costs. In: Drummond MF, Maguire A, eds. Economic evaluation in health care: merging theory and practice. New York: Oxford University Press, 2001;:94-112.
20. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. 62nd edn. London: BMJ Books, 2011.
21. Department of Health. NHS Reference Costs 2009/10. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459 (22 October 2012, date last accessed).
22. Curtis L. Unit Costs of Health and Social Care 2010. Personal Social Services Research Unit. http://www.pssru.ac.uk/archive/pdf/uc/uc2010/uc2010.pdf (22 October 2012, date last accessed).
23. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005.
24. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ 1998;317:1195-200.
25. Latimer N, Lord J, Grant RL, et al. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 2009;339: b2538c.